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1540Objective: The superior hemodynamics and excellent long-term clinical performance of stentless xenografts are
well described. However, the early and midterm clinical outcomes of stentless valves in patients with acute type
A dissection are widely unknown. The current study evaluated the early and midterm clinical outcomes of stent-
less bioprosthesis for repair of acute type A aortic dissection.
Methods: Between May 2005 and December 2009, 24 of 80 patients underwent root replacement using the
Medtronic Freestyle xenograft (Medtronic Inc, Minneapolis, Minn) at the Meijer Heart Center. Prospective
data collection was used for retrospective review. Univariate comparisons of preoperative, intraoperative, and
postoperative variables were performed between patients who underwent stentless root bioprosthesis for the
correction of acute type A aortic dissection (n ¼ 24).
Results: The mean age of patients was 57 years, with 15 patients aged less than 65 years. Axillary and femoral
artery cannulation were used in 16 patients (67%) and 7 patients (29%), respectively. Median crossclamp and
cardiopulmonary bypass times were 198 minutes (92-480 minutes) and 288 minutes (109-588 minutes), respec-
tively. Median circulatory arrest time was 28 minutes (24-50 minutes). Operative mortality rate was 25%.
Actuarial 5-year survival was 62.5%. No patients required redo aortic root replacement.
Conclusions: Stentless valve implantation can be accomplished with satisfactory early and midterm
clinical outcomes and is a valuable option in patients with acute aortic dissection who require root replacement.
(J Thorac Cardiovasc Surg 2013;145:1540-4)Acute aortic dissection of the ascending aorta is commonly
a life-threatening condition that requires emergency surgi-
cal intervention.1 Standard surgical therapy consists of re-
placing the ascending aorta with resection of the entry
tear. There is still a debate regarding the preferable surgical
approach in patients who require aortic root replacement.
A variety of aortic root replacement techniques have been
explored to identify the best approach. The gold standard
has been the Bentall procedure in which the root is replaced
by a mechanical valve-conduit. The Freestyle stentless aor-
tic root bioprosthesis (Medtronic Inc, Minneapolis, Minn)
was approved for clinical use in November 1997 and has
been associated with superior hemodynamic performance,
durability, and survival compared with stented xenograft
valves.2-4 The stentless root allows for a larger effective
orifice area, thereby producing lower gradients and
decreasing the likelihood of aortic regurgitation.5
Although the hemodynamic performance of the stentless
root is well documented, there is a paucity of studies inves-
tigating its use in patients with type A aortic dissection. Oure Department of Thoracic and Cardiovascular Surgery, Meijer Heart Center,
rworth Hospital, Grand Rapids, Mich.
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The Journal of Thoracic and Cardiovascular Surstudy sought to examine the early and midterm clinical
outcomes of aortic root replacement with stentless aortic
root bioprosthesis in patients with type A aortic dissection.PATIENTS AND METHODS
Patients
The database of the Division of Cardiothoracic Surgery at the Meijer
Heart Center was queried and identified 24 of 80 patients who underwent
repair of acute type A dissection and aortic root replacement with the Free-
style stentless root bioprosthesis between May 2005 and December 2009.
Of the 80 patients who had repair of aortic dissection at the Meijer Heart
Center, 39 had aortic root replacement (stentless root ¼ 24, mechanical
valved or tissue valved conduit ¼ 15), 4 had aortic valve replacement, 22
had aortic valve resuspension, and 15 had ascending aortic replacement
only without intervention in the aortic valve. Computed tomography
(CT) angiogram or transesophageal echocardiography was used to make
the diagnosis of aortic dissection that was confirmed at the time of opera-
tion. The same group of cardiac surgeons performed the operations for the
study period. Baseline demographic, procedural data, and preoperative
outcomes were recorded and entered prospectively in a prespecified data-
base by dedicated data-coordinating personnel. The Society of Thoracic
Surgeons’ national cardiac surgery database definitions were used for
this study.
Long-term survival data were obtained from the Social Security Death
Index website (http://ssdi.rootsweb.ancestry.com). Patients were followed
up on a regular basis at the office with repeat CT angiogram of the chest,
abdomen, and pelvis, as well as transthoracic echocardiography.
Study Design and Conduct
This is a retrospective study of prospectively collected data from con-
secutive patients who underwent aortic root replacement and repair of
acute type A dissection at the Meijer Heart Center. Study approval was
sought and obtained from the institutional review board. Patientgery c June 2013
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Insurance Portability and Accountability Act of 1996 regulations.
Operative Technique
A median sternotomy was performed, and patients were placed on
cardiopulmonary bypass with venous cannulation of the right atrium and
common femoral or right axillary artery cannulation. The axillary artery
was cannulated by anastomosing a tube graft and inserting a cannula inside
the tube graft. Myocardial protection was obtained with cold-blood cardi-
oplegia solution given retrograde via the coronary sinus or antegrade
directly down the ostia of the coronary arteries. A left ventricular vent
was placed via the right superior pulmonary vein. Hypothermic circulatory
arrest was used in most cases, and the arch was inspected for tears in those
patients. The goals of surgery were to resect the intimal tear, replace the
ascending aorta with a prosthetic graft, and restore the anatomy of the aor-
tic root. This study included patients in whom the aortic root or valve was
deemed to be involved beyond repair, necessitating aortic root replacement
with a Medtronic Freestyle stentless root bioprosthesis and reimplanting
the coronary buttons. The proximal and distal suture lines were reinforced
with Teflon (polytetrafluoroethylene) strips, and in some cases biological
glue (BioGlue surgical adhesive; Cryolife Inc, Kennesaw, Ga) was used
to reapproximate the dissected layers. After completion of the distal anas-
tomosis, antegrade aortic perfusion was established in both groups. The
Freestyle root was sewn into the aortic annulus with interrupted sutures.
Whenever the porcine ostia were aligned with the patient’s coronary but-
tons, the left main button was implanted on the left coronary ostium of
the porcine root and the right coronary button was implanted on the right
coronary ostium of the porcine root. Whenever such an orientation was an-
atomically not possible, the Freestyle root was implanted in a heterotopic
position with the left main button implanted on the right coronary ostium of
the porcine root and the right coronary button implanted on a custom-made
orifice created at the noncoronary sinus of the porcine root.
Data Analysis
Continuous variables were summarized using medians and ranges,
and frequencies and percentages were reported for categoric variables.
A Kaplan–Meier curve to depict survival was created.RESULTS
Preoperative Characteristics
Preoperative characteristics are presented in Table 1.
Nine women (37.5%) with acute type A aortic dissection
underwent aortic root replacement using the Medtronic
Freestyle xenograft. The median age for both men and
women was 57 years (range, 43-82 years). Fifteen patients
were aged less than 65 years (63%), and 5 of them were
aged less than 50 years (21%).Operative Characteristics
Operative patient characteristics of those who underwent
stentless root bioprosthesis for repair of type A aortic
dissection are presented in Table 2. Two patients (8.3%) re-
quired total arch replacement. Antegrade cerebral perfusionThe Journal of Thoracic and Carwas used more commonly than retrograde cerebral perfu-
sion. There were 5 patients with dissection involving the
left coronary button; in 3 of them, BioGlue was used to
approximate the layers. One patient had the coronary wall
layers reapproximated with interrupted Prolene sutures,
and reconstruction of the button was not feasible in 1 pa-
tient, who underwent vein bypass grafts to the left anterior
descending and obtuse marginal coronary arteries.
Postoperative Characteristics
Postoperative characteristics are shown in Table 3. Oper-
ative mortality rate was 25%. The most common cause of
death was cardiac. Of the 7 patients who had a stroke, 2
had femoral cannulation and 5 had axillary cannulation.
Of the 3 patients who had neurologic death, only 1 pre-
sented with neurologic symptoms before surgery. Of the 7
patients who had stroke, 1 presented with stroke symptoms
(left hemiplegia) before surgery, 3 had their dissection
extending into the arch and underwent arch replacement,
and 4 did not have arch replacement. Head CT findings
included no acute ischemia in 1 patient, but with clinical
evidence of stroke: chronic small vessel changes, middle
cerebral artery infarct, and reduced attenuation of both
hemispheres and density of the right cerebellum. Two pa-
tients never received a head CT but were diagnosed with
stroke from clinical symptoms.
Survival and Freedom From Structural
Degeneration
Follow-up was 100% complete. The mean follow-up
time was 717  730 days. Two patients died 132 and 489
days after surgery. Survival at 1, 3, and 5 years was
66.7%, 62.5%, and 62.5%, respectively (Figure 1). Free-
dom from structural valve degeneration was 100%. The
mean peak gradient at the end of the follow-up time was
6.5 2.1 mmHg (median peak gradient, 6.5 mmHg; range,
3.5-10 mm Hg) (Table 4). No patients required redo aortic
root replacement. Thirteen patients had no aortic insuffi-
ciency (AI), 2 patients had mild AI, and 1 patient had
mild to moderate AI at the end of the follow-up time. Six
patients had patent false lumen, and 9 patients had throm-
bosed false lumen or no residual dissection. One patient
had aneurysmal dilatation of the aortic arch, but she refused
arch replacement.
DISCUSSION
To the best of our knowledge, the current study is the first
to report the use of the Medtronic Freestyle stentless aortic
root bioprosthesis in the specific repair of patients with type
A aortic dissection. Past studies have shown the stentless
root bioprosthesis to be an excellent choice in the repair
of aortic root disease.6-8 Superior flow patterns, durability,
and increased survival compared with stented xenograft
valves have gained the stentless root bioprosthesisdiovascular Surgery c Volume 145, Number 6 1541
TABLE 1. Preoperative patient characteristics
n ¼ 24 %
Age (median, range in years) 57 (43-82)
Female gender 9 37.5
Diabetes 2 8.3
Congestive heart failure 14 58.3
Hypertension 20 83.3
Chronic renal insufficiency 1 4.2
Hemodialysis 0 0
Chronic obstructive lung disease (moderate/severe) 1 4.2
History of myocardial infarction 2 8.3
History of cerebrovascular accident 1 4.2
Arrhythmia 3 12.5
No. of diseased vessels
1 1 4.2
2 0 0
3 3 12.5
Numbers are expressed as or as median and range.
TABLE 3. Postoperative patient characteristics
n ¼ 24 %
Hemorrhage-related reexploration 2 8.3
Deep sternal wound infection 1 4.2
Acute renal failure 7 29.2
Postoperative hemodialysis 3 12.5
Prolonged ventilation (>24 h) 17 70.8
Cardiac arrest 3 12.5
Pericardial tamponade 2 8.3
Atrial fibrillation 6 25
Cerebrovascular accident 7 29.2
Length of stay in days (median/range) 13.5 (1-45)
Prolonged length of stay (>14 d) 12 50
Operative mortality 6 25
Cause of operative mortality
Cardiac 2 33
Pulmonary 1 17
Neurologic 3 50
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the stentless root bioprosthesis is the more difficult
mounting compared with stented xenografts and the more
limited durability compared with the mechanical valve-
conduit.2,7,8 Root replacement with the Freestyle stentless
valve has been shown to be effective in the treatment of
adults of all ages, including those with small aortic
roots.6,8-11 Our study specifically shows that acceptable
results can be obtained through the use of the stentlessTABLE 2. Operative patient characteristics
n ¼ 24 %
Coronary artery bypass grafting 2 8.3
Mitral and tricuspid valve replacement 1 4.2
Implantation of left ventricular assist device 1 4.2
Total arch replacement 2 8.3
Intraoperative blood transfusion 19 79.2
Postoperative blood transfusion 20 83.3
Crossclamp time (median/range) 198 (92-480)
Perfusion time (median/range) 288 (109-588)
Circulatory arrest time (median/range) 28 (24-50)
AI
Trivial 3 12.5
Mild 5 20.8
Moderate 2 8.3
Severe 7 29.2
None 6 25
Arterial cannulation
Aorta 1 4.2
Axillary 16 66.7
Femoral 7 29.2
Hemodynamic instability 3 12.5
Retrograde cerebral profusion 3 12.5
Antegrade cerebral perfusion 10 41.7
Use of biological glue 15 62.5
Numbers are expressed as or as median and range. AI, Aortic insufficiency.
1542 The Journal of Thoracic and Cardiovascular Surroot bioprosthesis for root replacement in patients with
type A aortic dissection.Operative Mortality and Morbidity
We conducted an observational study within the Meijer
Heart Center to examine the result of stentless root biopros-
thesis in the repair of acute type A aortic dissection. On the
basis of our findings, stentless root bioprosthesis is a feasible
option in patients with ascending aortic root dissection who
require aortic root replacement. There were 2 late deaths
132 and 489 days after surgery. The operative mortality
rate in this study was comparable to the rates recorded in
the literature for type A dissection (20%-37.5%).10,12,13
Implantation of a stentless root bioprothesis requires
more operative time than stented root xenografts. Studies
have shown that although the stentless root replacement
takes longer to complete, the operative time has not resulted
in increased morbidity or mortality.4,8 Likewise, a study by
Kon and colleagues4 showed no significant difference in
bleeding complications associated with the stentless root
bioprosthesis despite the increased operative complexity.
Bach and colleagues5 demonstrated operative risk and
mortality to be reduced substantially by increased surgeon
experience. Higher operative mortality was generally asso-
ciated with prolonged myocardial ischemia, increased risk
of bleeding complications, and more technically challeng-
ing implant of the stentless root, which may be the reason
some surgeons favor root replacement with stented xeno-
graft or mechanical valve conduit.4,8,14-16
Another issue is the durability of the stentless root bio-
prosthesis in younger patients with type A dissection. In
the current study, the mean age of the patient cohort was
57 years, and 15 patients were aged less than 65 years. Desai
and colleagues17 examined the durability of the Medtronic
stentless root bioprosthesis in younger patients for a varietygery c June 2013
FIGURE 1. Actuarial 5-year survival curve for patients who had root re-
placement with stentless root bioprosthesis for repair of acute type A aortic
dissection (Kaplan–Meier survival estimates). The number at risk is ad-
justed taking into account mortality along with variations in length of
follow-up time.
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prosthesis to have excellent durability along with decreased
anticoagulant-related bleeding compared with mechanical
roots at 5 and 10 years of follow-up.17 There was no notice-
able difference in early or midterm mortality between the
stentless and the mechanical valve conduit.17 This success
is likely attributable to the superior hemodynamics and
durability of the stentless bioprosthesis seen in older pa-
tients.2,4,17 The study by Desai and colleagues17 is in agree-
ment with previous studies showing the stentless root
bioprosthesis in young patients to have excellent durability
and clinical outcomes at 12 years of follow-up.18
Clinical Implications
This study is among the first in the literature to describe
the use of the Freestyle stentless aortic root bioprosthesis in
the specific repair of patients with type A aortic dissection.
Data were prospectively acquired on a cohort of patients
with the assistance of meticulous data-management person-
nel. Our results suggest that stentless root bioprosthesis may
be used for aortic root replacement with acceptable early
outcomes and midterm survival in patients with type A dis-
section. Freestyle stentless root bioprosthesis also may beTABLE 4. Mean peak gradients
Size of bioprosthesis (mm) Total (%) Dp Mean (mm Hg) ± SD
All 100 6.5  2.1
23 8 9  0
25 17 6.8  3.3
27 25 5.8  1.4
29 50 6.4  1.8
Values are expressed as% or as mean  SD. SD, Standard deviation.
The Journal of Thoracic and Carconsidered as a choice for root replacement in patients
with type A dissection who are aged less than 65 years
and do not want to take warfarin (Coumadin; Bristol-
Myers Squibb, New York, NY). Stentless roots allow the
removal of more diseased aortic tissue (dissected sinuses)
and in some cases can actually simplify this operation and
result in decreased bleeding complications. In the current
study, no patients required redo aortic root replacement
with a median follow-up time of 875 days (range, 1-2035
days).
Study Limitations
Limitations of this study include those inherent in a retro-
spective single-institution methodology. The fact that more
than 1 surgeon operated on the patients in this study may
have introduced bias. Investigation into the causes of mid-
termmortality was not available during our study. The small
sample size (n ¼ 24), due mainly to the infrequency of aor-
tic root replacement for type A aortic dissection, is another
limitation of our study. The small sample size did not allow
comparison between the Freestyle root and the non-
Freestyle root replacement and will be a focus of future
studies. More studies are required to confirm the durability,
freedom from structural valve degeneration, and midterm
clinical outcomes of this subset of patients.
CONCLUSIONS
Full-root stentless valve implantation is a valuable option
in patients with acute aortic dissection who require root
replacement. Although this method is technically a more
challenging operation, it is associated with acceptable early
and midterm clinical outcomes.
The authors thank Dr Alan Davis for the invaluable contribution
to the statistical analysis of the article.
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